Café

© 2026 Longbridge｜Terms of Service Privacy Policy

ALT

ALT

2.9802.05%( +0.060 )

LongbridgeAI

Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026 | ALT Stock News

StockTitan

May 12, 2026 at 10:20 PM

Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026 | ALT Stock News

Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026 | ALT Stock News

Login to unlock148characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Altimmune

USALT

+2.05%

Invesco Nasdaq Biotechnology ETF

USIBBQ

VG Health

USVHT